The Medicines Company: Novartis' Takeover Of Medicines Puts The Spotlight On These Biotechs

Shares of RNA interference biotech companies surged Monday after Novartis announced its $9.7 billion takeover of The Medicines Company, adding a promising cholesterol drug to its wheelhouse.The post Novartis' Takeover Of Medicines Puts The Spotlight On These Biotechs appeared first on Investor's Business Daily.